HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to Leishmania (Vianna) braziliensis.

Abstract
We report for the first time the successful use of fluconazole to treat cutaneous leishmaniasis due to Leishmania braziliensis. We used escalating doses from 5 to 8 mg/kg per day. At a dose of 5 mg/kg per day, 75% patients were cured, and at 8 mg/kg per day, the cure rate was 100%. Fluconazole was well tolerated.
AuthorsAnastácio Q Sousa, Mércia S Frutuoso, Elisabete A Moraes, Richard D Pearson, Margarida M L Pompeu
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 53 Issue 7 Pg. 693-5 (Oct 2011) ISSN: 1537-6591 [Electronic] United States
PMID21890773 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antiprotozoal Agents
  • Fluconazole
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiprotozoal Agents (administration & dosage, adverse effects)
  • Child
  • Child, Preschool
  • Female
  • Fluconazole (administration & dosage, adverse effects)
  • Humans
  • Leishmania braziliensis (drug effects, isolation & purification)
  • Leishmaniasis, Cutaneous (drug therapy, parasitology)
  • Male
  • Middle Aged
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: